Visionaire Health Economics Study Comparing Economic Outcomes Between Visionaire and Standard Instrumentation
NCT ID: NCT02158819
Last Updated: 2019-01-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
52 participants
INTERVENTIONAL
2014-07-09
2017-05-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
VISIONAIRE™ Value Study
NCT01107769
Visionaire™ Versus Standard Instrumentation Safety and Efficacy in Total Knee Arthroplasty (TKA)
NCT01084772
Assessment of Conventional and Patient-specific Instrumentation in Total Knee Arthroplasty
NCT02230215
Visionaire: A Prospective Study
NCT01937572
Custom Cutting Block Instrument vs Regular Instrumentation Total Knee Replacement (TKR)
NCT03416946
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The primary objective of this study will evaluate the cost of the episode of care from hospital admission to discharge. This will include pre-operative costs, anesthetic costs, operative and theatre costs, costs of instruments and resources. The study will also measure length of stay as well as blood transfusion requirements. The secondary objectives of this study are to compare the safety and early readmission rates between the two techniques, by measuring the complication rates intra-operatively and post-operatively as well as the number of patients readmitted to hospital prior to the six week post-operative assessment.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TKA with standard instrumentation
This arm consists of the Genesis II Total knee implant system or the Legion Primary total knee system with standard instrumentation
No interventions assigned to this group
Total knee arthroplasty with Visionaire
This arm will consist of the Genesis II Total Knee Implant System or Legion Primary Total Knee System with the Visionaire patient-matched instrumentation
Total knee arthroplasty with Visionaire
Patient Specific Instrumentation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Total knee arthroplasty with Visionaire
Patient Specific Instrumentation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient is of legal age to consent and is skeletally mature;
* The patient is able to fully understand the purpose of the trial, and his/her role as a participant in the study
* The patient consents to his/her inclusion in the study after the nature, scope and possible consequences of the study have been explained in an understandable form.
Exclusion Criteria
* Patient is immuno-suppressed.
* Patient has physical, emotional or neurological conditions that would compromise the subject's compliance with postoperative rehabilitation and follow-up.
* Patient is pregnant or may become pregnant during the course of the study, or is lactating.
* Patient has a history of prior ipsilateral major knee surgery (e.g. arthroplasty, high tibial osteotomy, or tibial plateau fracture). Minor prior procedures such as Anterior Cruciate Ligament repair, meniscectomy, or arthroscopy are not excluded.
* Patient has active, localized or systemic infection.
* Patient is severely overweight (BMI \>40).
* Patient is a prisoner.
* Patient has a significant MRI (magnetic resonance imaging) exclusion or contraindication.
* Patient has had a total joint arthroplasty of the contralateral limb in the last 12 months.
* Patient presently identified with future need for bilateral TKA within the next twenty-four months.
* Patient has a known or suspected hypersensitivity/allergy to foreign materials contained in the implant
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Smith & Nephew, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andrew Baker
Role: PRINCIPAL_INVESTIGATOR
Private Practice
Lieth Stewart
Role: PRINCIPAL_INVESTIGATOR
Life Claremont Hospital
Willem Tollig
Role: PRINCIPAL_INVESTIGATOR
Pretoria East Hospital
Michael Barrow
Role: PRINCIPAL_INVESTIGATOR
Sunninghill Hospital
Dan Potgieter
Role: PRINCIPAL_INVESTIGATOR
Life Bay View Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Life Bay View Hospital
Mossel Bay, Cape Town, South Africa
Sunninghill Hospital
Johannesburg, Gauteng, South Africa
Pretoria East Hospital
Pretoria, Gauteng, South Africa
Private Practice
Durban, KwaZulu-Natal, South Africa
Life Claremont Hospital
Cape Town, Western Cape, South Africa
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VISHE.13
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.